Explore the complexities of primary and secondary resistance in EGFR-mutated non-small cell lung cancer through this informative 44-minute video lecture. Gain insights into the latest research, treatment strategies, and clinical implications of resistance mechanisms in EGFR-targeted therapies. Delve into the challenges faced by oncologists and researchers in overcoming these resistance patterns to improve patient outcomes. Learn about emerging approaches and potential future directions in managing EGFR-mutated lung cancer patients who develop resistance to targeted therapies.
Overview
Syllabus
EGFR: The Challenge of Primary and Secondary Resistance
Taught by
HMP Education
Related Courses
-
The Era of Precision Medicine - From EGFR Discovery to Future Cancer Treatment
-
Understanding and Overcoming PARP Inhibitor Resistance
-
The Era of ADCs in the Treatment of NSCLC
-
Two Co-occurring Driver Mutations in Primary Lung Adenocarcinoma - Who's Driving Treatment?
-
Treatment for Lung Cancer - Jay Lee, MD and Jonathan Goldman, MD - UCLAMDChat
5.0 -
Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer
